13 Lots of EpiPen and EpiPen Jr Recalled — Physician’s First Watch

Medical News |
April 3, 2017

13 Lots of EpiPen and EpiPen Jr Recalled

By Amy Orciari Herman

Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

Thirteen lots of Mylan's EpiPen and EpiPen Jr auto-injectors are being recalled because the devices may have a defect that could interfere with their activation in emergency situations.

The recall follows reports of two devices that failed to activate "due to a potential defect in a supplier component," according to Mylan's press release.

The recalled lots were distributed between December 2015 and July 2016. A list of the lot numbers is available at the link below. Mylan is asking that patients with recalled EpiPens keep their current devices until they receive a replacement; guidance for affected patients is also linked below.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.